CD4 and infection: In particular, humoral and cellular immunity induced by RZV are obtained through the synergy between the adjuvant AS01B, a potent initiator of the immune cell-mediated response, and recombinant VZV gE, final target of specific CD4 + T cells and antibodies in both primary infection and vaccination induced [10].